A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

NCT07544056 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

446

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Triple-negative Breast Cancer
Metastatic Triple-negative Breast Cancer

Interventions

DRUG: BEBT-209 capsules
DRUG: Carboplatin Injection
DRUG: Gemcitabine Hydrochloride for Injection

Sponsor

BeBetter Med Inc

Collaborators

[object Object]
[object Object]